| |
U133
probe set
|
Gene description
|
Symbol
|
Location
|
GenBank Reference
|
Chi-square
|
T-ALL above/below mean
|
Fold change
|
old or new
|
|
1
|
201137_s_at
|
major histocompatibility complex, class II, DP beta
1
|
HLA-DPB1
|
6p21.3
|
NM_002121.1
|
100.0
|
Below
|
21.0
|
old
|
|
2
|
202113_s_at
|
sorting nexin 2
|
SNX2
|
5q23
|
AF043453.1
|
100.0
|
Below
|
4.2
|
old
|
|
3
|
202114_at
|
sorting nexin 2
|
SNX2
|
5q23
|
NM_003100.1
|
100.0
|
Below
|
4.6
|
old
|
|
4
|
203675_at
|
nucleobindin 2
|
NUCB2
|
11p15.1-p14
|
NM_005013.1
|
100.0
|
Above
|
3.6
|
old
|
|
5
|
204670_x_at
|
major histocompatibility complex, class II, DR beta
3
|
HLA-DRB3
|
6p21.3
|
NM_002125.1
|
100.0
|
Below
|
13.4
|
old
|
|
6
|
205297_s_at
|
CD79B antigen (immunoglobulin-associated beta)
|
CD79B
|
17q23
|
NM_000626.1
|
100.0
|
Below
|
23.3
|
old
|
|
7
|
205456_at
|
CD3E antigen, epsilon polypeptide (TiT3 complex)
|
CD3E
|
11q23
|
NM_000733.1
|
100.0
|
Above
|
20.7
|
old
|
|
8
|
206398_s_at
|
CD19 antigen
|
CD19
|
16p11.2
|
NM_001770.1
|
100.0
|
Below
|
5693.6
|
old
|
|
9
|
208306_x_at
|
major histocompatibility complex, class II, DR beta
4
|
HLA-DRB4
|
6p21.3
|
NM_021983.2
|
100.0
|
Below
|
8.3
|
old
|
|
10
|
208894_at
|
major histocompatibility complex, class II, DR alpha
|
HLA-DRA
|
6p21.3
|
M60334.1
|
100.0
|
Below
|
20.9
|
old
|
|
11
|
209312_x_at
|
major histocompatibility complex, class II, DR beta
1
|
HLA-DRB1
|
6p21.3
|
U65585.1
|
100.0
|
Below
|
12.6
|
old
|
|
12
|
209619_at
|
CD74 antigen (invariant polypeptide of major histocompatibility
complex, class II antigen-associated)
|
CD74
|
5q32
|
K01144.1
|
100.0
|
Below
|
15.1
|
old
|
|
13
|
210116_at
|
SH2 domain protein 1A, Duncan's disease (lymphoproliferative
syndrome)
|
SH2D1A
|
Xq25-q26
|
AF072930.1
|
100.0
|
Above
|
150.7
|
old
|
|
14
|
210982_s_at
|
major histocompatibility complex, class II, DR alpha
|
HLA-DRA
|
6p21.3
|
M60333.1
|
100.0
|
Below
|
23.4
|
old
|
|
15
|
211990_at
|
major histocompatibility complex, class II, DP alpha
1
|
HLA-DPA1
|
6p21.3
|
M27487.1
|
100.0
|
Below
|
19.6
|
old
|
|
16
|
211991_s_at
|
major histocompatibility complex, class II, DP alpha
1
|
HLA-DPA1
|
6p21.3
|
M27487.1
|
100.0
|
Below
|
24.5
|
old
|
|
17
|
213539_at
|
CD3D antigen, delta polypeptide (TiT3 complex)
|
CD3D
|
11q23
|
NM_000732.1
|
100.0
|
Above
|
35.7
|
old
|
|
18
|
214049_x_at
|
CD7 antigen (p41)
|
CD7
|
17q25.2-q25.3
|
AI829961
|
100.0
|
Above
|
312.2
|
old
|
|
19
|
214551_s_at
|
CD7 antigen (p41)
|
CD7
|
17q25.2-q25.3
|
NM_006137.2
|
100.0
|
Above
|
228.1
|
old
|
|
20
|
217147_s_at
|
T-cell receptor interacting molecule
|
TRIM
|
3q13
|
AJ240085.1
|
100.0
|
Above
|
42.6
|
new
|
|
21
|
217478_s_at
|
MHC, class IIa, HLA-DMA
|
HLA-DMA
|
|
X76775
|
100.0
|
Below
|
11.9
|
old
|
|
22
|
221969_at
|
paired box gene 5 (B-cell lineage specific activator
protein)
|
PAX5
|
9p13
|
BF510692
|
100.0
|
Below
|
3922.0
|
new
|
|
23
|
227646_at
|
early B-cell factor
|
EBF
|
5q34
|
BG435302
|
100.0
|
Below
|
85.0
|
new
|
|
24
|
229487_at
|
cDNA FLJ39389 fis
|
FLJ39389
|
5
|
W73890
|
100.0
|
Below
|
7685.7
|
new
|
|
25
|
229838_at
|
cDNA FLJ39156 fis
|
FLJ39156
|
|
AI377271
|
100.0
|
Above
|
12.7
|
old
|
|
26
|
232204_at
|
early B-cell factor
|
EBF
|
5q34
|
AF208502.1
|
100.0
|
Below
|
7129.1
|
new
|
|
27
|
203965_at
|
ubiquitin specific protease 20
|
USP20
|
9q34.12-q34.13
|
NM_006676.1
|
91.3
|
Above
|
9.0
|
old
|
|
28
|
204891_s_at
|
lymphocyte-specific protein tyrosine kinase
|
LCK
|
1p34.3
|
NM_005356.1
|
91.3
|
Above
|
13.8
|
old
|
|
29
|
205255_x_at
|
transcription factor 7 (T-cell specific, HMG-box)
|
TCF7
|
5q31.1
|
NM_003202.1
|
91.3
|
Above
|
8.4
|
old
|
|
30
|
207655_s_at
|
B-cell linker
|
BLNK
|
10q23.2-q23.33
|
NM_013314.1
|
91.3
|
Below
|
103.2
|
old
|
|
31
|
209771_x_at
|
CD24 antigen (small cell lung carcinoma cluster
4 antigen)
|
CD24
|
6q21
|
AA761181
|
91.3
|
Below
|
40.1
|
old
|
|
32
|
211796_s_at
|
T cell receptor beta locus
|
TRB
|
7q34
|
AF043179.1
|
91.3
|
Above
|
20.7
|
old
|
|
33
|
213792_s_at
|
insulin receptor
|
INSR
|
19p13.3-p13.2
|
AA485908
|
91.3
|
Below
|
8.0
|
old
|
|
34
|
215193_x_at
|
major histocompatibility complex, class II, DR beta
3
|
HLA-DRB3
|
6p21.3
|
AJ297586.1
|
91.3
|
Below
|
12.1
|
old
|
|
35
|
216379_x_at
|
KIAA1919 protein
|
KIAA1919
|
6q22.1
|
AK000168.1
|
91.3
|
Below
|
44.0
|
old
|
|
36
|
219191_s_at
|
bridging integrator 2
|
BIN2
|
12q13
|
NM_016293.1
|
91.3
|
Above
|
271.0
|
new
|
|
37
|
219563_at
|
hypothetical protein FLJ21276
|
FLJ21276
|
14q32.2
|
NM_024633.1
|
91.3
|
Below
|
5.8
|
new
|
|
38
|
219724_s_at
|
KIAA0748 gene product
|
KIAA0748
|
12q12
|
NM_014796.1
|
91.3
|
Above
|
11.6
|
new
|
|
39
|
221750_at
|
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1
(soluble)
|
HMGCS1
|
5p14-p13
|
BG035985
|
91.3
|
Above
|
3.4
|
new
|
|
40
|
226157_at
|
cDNA FLJ39131 fis
|
FLJ39131
|
3
|
AI569747
|
91.3
|
Above
|
4.4
|
old
|
|
41
|
226496_at
|
hypothetical protein FLJ22611
|
FLJ22611
|
9p11.1
|
BG291039
|
91.3
|
Below
|
7.6
|
new
|
|
42
|
266_s_at
|
CD24 antigen (small cell lung carcinoma cluster
4 antigen)
|
CD24
|
6q21
|
L33930
|
91.3
|
Below
|
69.7
|
old
|
|
43
|
39318_at
|
T-cell leukemia/lymphoma 1A
|
TCL1A
|
14q32.1
|
X82240
|
91.3
|
Below
|
367.4
|
old
|
|
44
|
204214_s_at
|
RAB32, member RAS oncogene family
|
RAB32
|
6q24.3
|
NM_006834.1
|
90.6
|
Above
|
127.9
|
new
|
|
45
|
204777_s_at
|
mal, T-cell differentiation protein
|
MAL
|
2cen-q13
|
NM_002371.2
|
90.6
|
Above
|
96.8
|
old
|
|
46
|
204890_s_at
|
lymphocyte-specific protein tyrosine kinase
|
LCK
|
1p34.3
|
U07236.1
|
90.6
|
Above
|
18.6
|
old
|
|
47
|
205049_s_at
|
CD79A antigen (immunoglobulin-associated alpha)
|
CD79A
|
19q13.2
|
NM_001783.1
|
90.6
|
Below
|
11.4
|
old
|
|
48
|
205254_x_at
|
transcription factor 7 (T-cell specific, HMG-box)
|
TCF7
|
5q31.1
|
AW027359
|
90.6
|
Above
|
352.0
|
old
|
|
49
|
205504_at
|
Bruton agammaglobulinemia tyrosine kinase
|
BTK
|
Xq21.33-q22
|
NM_000061.1
|
90.6
|
Below
|
6.6
|
old
|
|
50
|
210915_x_at
|
T cell receptor beta locus
|
TRB
|
7q34
|
M15564.1
|
90.6
|
Above
|
15.9
|
old
|
|
51
|
211211_x_at
|
SH2 domain protein 1A, Duncan's disease (lymphoproliferative
syndrome)
|
SH2D1A
|
Xq25-q26
|
AF100542.1
|
90.6
|
Above
|
1963.5
|
old
|
|
52
|
213830_at
|
T cell receptor delta locus
|
TRD
|
14q11.2
|
AW007751
|
90.6
|
Above
|
7411.2
|
old
|
|
53
|
216191_s_at
|
T cell receptor delta locus
|
TRD
|
14q11.2
|
X72501.1
|
90.6
|
Above
|
253.7
|
old
|
|
54
|
217143_s_at
|
T cell receptor delta locus
|
TRD
|
14q11.2
|
X06557.1
|
90.6
|
Above
|
151.9
|
old
|
|
55
|
219528_s_at
|
B-cell CLL/lymphoma 11B (zinc finger protein)
|
BCL11B
|
14q32.31-q32.32
|
NM_022898.1
|
90.6
|
Above
|
11.6
|
new
|
|
56
|
220418_at
|
ubiquitin associated and SH3 domain containing,
A
|
UBASH3A
|
21q22.3
|
NM_018961.1
|
90.6
|
Above
|
759.3
|
new
|
|
57
|
222895_s_at
|
B-cell CLL/lymphoma 11B (zinc finger protein)
|
BCL11B
|
14q32.31-q32.32
|
AA918317
|
90.6
|
Above
|
11.7
|
new
|
|
58
|
223553_s_at
|
hypothetical protein FLJ22570
|
FLJ22570
|
5q35.3
|
BC004564.1
|
90.6
|
Below
|
6.1
|
new
|
|
59
|
225090_at
|
HRD1 protein
|
HRD1
|
11q12
|
AA844682
|
90.6
|
Below
|
3.6
|
new
|
|
60
|
226459_at
|
Homo sapiens gastric cancer-related protein GCYS-20
(gcys-20) mRNA, complete cds
|
|
|
AW575754
|
90.6
|
Below
|
10.7
|
new
|
|
61
|
228314_at
|
cDNA FLJ37485 fis
|
FLJ37485
|
|
BE877357
|
90.6
|
Below
|
4.7
|
new
|
|
62
|
201384_s_at
|
membrane component, chromosome 17, surface marker
2 (ovarian carcinoma antigen CA125)
|
M17S2
|
17q21.1
|
NM_005899.1
|
83.8
|
Above
|
3.3
|
new
|
|
63
|
202540_s_at
|
3-hydroxy-3-methylglutaryl-Coenzyme A reductase
|
HMGCR
|
5q13.3-q14
|
NM_000859.1
|
83.8
|
Above
|
4.4
|
old
|
|
64
|
203198_at
|
cyclin-dependent kinase 9 (CDC2-related kinase)
|
CDK9
|
9q34.1
|
NM_001261.1
|
83.8
|
Below
|
4.8
|
old
|
|
65
|
203932_at
|
major histocompatibility complex, class II, DM beta
|
HLA-DMB
|
6p21.3
|
NM_002118.1
|
83.8
|
Below
|
7.9
|
old
|
|
66
|
204613_at
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
PLCG2
|
16q24.1
|
NM_002661.1
|
83.8
|
Below
|
3.9
|
old
|
|
67
|
205267_at
|
POU domain, class 2, associating factor 1
|
POU2AF1
|
11q23.1
|
NM_006235.1
|
83.8
|
Below
|
11.2
|
old
|
|
68
|
208650_s_at
|
CD24 antigen (small cell lung carcinoma cluster
4 antigen)
|
CD24
|
6q21
|
BG327863
|
83.8
|
Below
|
74.7
|
old
|
|
69
|
208651_x_at
|
CD24 antigen (small cell lung carcinoma cluster
4 antigen)
|
CD24
|
6q21
|
M58664.1
|
83.8
|
Below
|
52.7
|
old
|
|
70
|
209995_s_at
|
T-cell leukemia/lymphoma 1A
|
TCL1A
|
14q32.1
|
BC003574.1
|
83.8
|
Below
|
20166.2
|
old
|
|
71
|
210038_at
|
protein kinase C, theta
|
PRKCQ
|
10p15
|
AL137145
|
83.8
|
Above
|
12.7
|
old
|
|
72
|
211126_s_at
|
cysteine and glycine-rich protein 2
|
CSRP2
|
12q21.1
|
U46006.1
|
83.8
|
Below
|
18.0
|
old
|
|
73
|
220068_at
|
pre-B lymphocyte gene 3
|
VPREB3
|
22q11.23
|
NM_013378.1
|
83.8
|
Below
|
6559.8
|
new
|
|
74
|
226245_at
|
cDNA DKFZp451C132
|
DKFZp451C132
|
|
U55984
|
83.8
|
Above
|
8.7
|
new
|
|
75
|
202615_at
|
cDNA DKFZp686D0521
|
DKFZp686D0521
|
|
BF222895
|
82.2
|
Above
|
3.1
|
old
|
|
76
|
224861_at
|
cDNA FLJ31057 fis
|
FLJ31057
|
|
BF477658
|
82.2
|
Above
|
3.5
|
new
|
|
77
|
201194_at
|
selenoprotein W, 1
|
SEPW1
|
19q13.3
|
NM_003009.1
|
82.0
|
Above
|
3.8
|
old
|
|
78
|
201349_at
|
solute carrier family 9 (sodium/hydrogen exchanger),
isoform 3 regulatory factor 1
|
SLC9A3R1
|
17q25.2
|
NM_004252.1
|
82.0
|
Above
|
2.9
|
old
|
|
79
|
202539_s_at
|
3-hydroxy-3-methylglutaryl-Coenzyme A reductase
|
HMGCR
|
5q13.3-q14
|
AL518627
|
82.0
|
Above
|
3.5
|
old
|
|
80
|
203588_s_at
|
transcription factor Dp-2 (E2F dimerization partner
2)
|
TFDP2
|
3q23
|
BG034328
|
82.0
|
Above
|
17.5
|
old
|
|
81
|
204852_s_at
|
protein tyrosine phosphatase, non-receptor type
7
|
PTPN7
|
1q32.1
|
NM_002832.1
|
82.0
|
Above
|
9.5
|
old
|
|
82
|
207434_s_at
|
FXYD domain containing ion transport regulator 2
|
FXYD2
|
|
